343 related articles for article (PubMed ID: 17502346)
1. Perinatal circulating visfatin levels in intrauterine growth restriction.
Malamitsi-Puchner A; Briana DD; Boutsikou M; Kouskouni E; Hassiakos D; Gourgiotis D
Pediatrics; 2007 Jun; 119(6):e1314-8. PubMed ID: 17502346
[TBL] [Abstract][Full Text] [Related]
2. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth.
Briana DD; Boutsikou M; Gourgiotis D; Kontara L; Baka S; Iacovidou N; Hassiakos D; Malamitsi-Puchner A
J Perinat Med; 2007; 35(4):326-9. PubMed ID: 17511597
[TBL] [Abstract][Full Text] [Related]
3. N-terminal parathyroid hormone-related protein levels in human intrauterine growth restricted pregnancies.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Marmarinos A; Iacovidou N; Malamitsi-Puchner A
Acta Obstet Gynecol Scand; 2007; 86(8):945-9. PubMed ID: 17653879
[TBL] [Abstract][Full Text] [Related]
4. Serum cystatin C in pregnancies with normal and restricted fetal growth.
Malamitsi-Puchner A; Briana DD; Kontara L; Boutsikou M; Baka S; Hassiakos D; Marmarinos A; Gourgiotis D
Reprod Sci; 2007 Jan; 14(1):37-42. PubMed ID: 17636214
[TBL] [Abstract][Full Text] [Related]
5. Circulating osteoprotegerin and sRANKL concentrations in the perinatal period at term. The impact of intrauterine growth restriction.
Briana DD; Boutsikou M; Baka S; Hassiakos D; Gourgiotis D; Malamitsi-Puchner A
Neonatology; 2009; 96(2):132-6. PubMed ID: 19365143
[TBL] [Abstract][Full Text] [Related]
6. Blood visfatin concentrations in normal full-term pregnancies.
Malamitsi-Puchner A; Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D
Acta Paediatr; 2007 Apr; 96(4):526-9. PubMed ID: 17391471
[TBL] [Abstract][Full Text] [Related]
7. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates.
Boutsikou T; Malamitsi-Puchner A; Economou E; Boutsikou M; Puchner KP; Hassiakos D
Early Hum Dev; 2006 Apr; 82(4):235-9. PubMed ID: 16337100
[TBL] [Abstract][Full Text] [Related]
8. [Relationship of adiponectin and visfatin with fetus intrauterine growth].
Shang LX; Tang QL; Wang J; Zhang F; Wu N; Wang SH; Li P
Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):246-8. PubMed ID: 19570458
[TBL] [Abstract][Full Text] [Related]
9. The effect of intrauterine growth restriction on circulating surfactant protein D concentrations in the perinatal period.
Briana DD; Gourgiotis D; Baka S; Boutsikou M; Vraila VM; Boutsikou T; Hassiakos D; Malamitsi-Puchner A
Reprod Sci; 2010 Jul; 17(7):653-8. PubMed ID: 20360592
[TBL] [Abstract][Full Text] [Related]
10. Perinatal bone turnover in term pregnancies: the influence of intrauterine growth restriction.
Briana DD; Gourgiotis D; Boutsikou M; Baka S; Hassiakos D; Vraila VM; Creatsas G; Malamitsi-Puchner A
Bone; 2008 Feb; 42(2):307-13. PubMed ID: 18024242
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of visfatin and adiponectin in pregnancies with normal and abnormal placental function.
Fasshauer M; Blüher M; Stumvoll M; Tönessen P; Faber R; Stepan H
Clin Endocrinol (Oxf); 2007 Mar; 66(3):434-9. PubMed ID: 17302880
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 in fetal serum correlates with insulin-like growth factor-I and fetal growth.
Ostlund E; Tally M; Fried G
Obstet Gynecol; 2002 Sep; 100(3):567-73. PubMed ID: 12220780
[TBL] [Abstract][Full Text] [Related]
13. The role of IGF-1 and ghrelin in the compensation of intrauterine growth restriction.
Kyriakakou M; Malamitsi-Puchner A; Mastorakos G; Boutsikou T; Hassiakos D; Papassotiriou I; Kanaka-Gantenbein C
Reprod Sci; 2009 Dec; 16(12):1193-200. PubMed ID: 19770497
[TBL] [Abstract][Full Text] [Related]
14. Enhanced circulating retinol and non-esterified fatty acids in pregnancies complicated with intrauterine growth restriction.
Ortega-Senovilla H; Alvino G; Taricco E; Cetin I; Herrera E
Clin Sci (Lond); 2009 Nov; 118(5):351-8. PubMed ID: 19656084
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum activin A and the prediction of intrauterine growth restriction.
Barkehall-Thomas A; Tong S; Baker LS; Edwards A; Wallace EM
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):97-101. PubMed ID: 16638029
[TBL] [Abstract][Full Text] [Related]
16. Serum fetuin-A/alpha2-HS-glycoprotein in human pregnancies with normal and restricted fetal growth.
Briana DD; Boutsikou M; Gourgiotis D; Boutsikou T; Baka S; Marmarinos A; Hassiakos D; Malamitsi-Puchner A
J Matern Fetal Neonatal Med; 2008 Nov; 21(11):826-30. PubMed ID: 19031279
[TBL] [Abstract][Full Text] [Related]
17. Effect of intrauterine growth pattern on serum visfatin concentrations in full-term infants at birth and at 6 months of life.
El Shemi MS; Mohamed MH; AbdelRahman AO; Abdel Al H; Ramadan NM
J Neonatal Perinatal Med; 2016; 9(1):73-82. PubMed ID: 27002258
[TBL] [Abstract][Full Text] [Related]
18. Endocrine regulation in asymmetric intrauterine fetal growth retardation.
Mahajan SD; Aalinkeel R; Singh S; Shah P; Gupta N; Kochupillai N
J Matern Fetal Neonatal Med; 2006 Oct; 19(10):615-23. PubMed ID: 17118735
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the maternal and umbilical interleukin-8 levels in normal pregnancies and in pregnancies complicated by preeclampsia with intrauterine normal growth and intrauterine growth retardation.
Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
J Matern Fetal Neonatal Med; 2007 Jul; 20(7):527-32. PubMed ID: 17674266
[TBL] [Abstract][Full Text] [Related]
20. Omentin-1 and vaspin are present in the fetus and neonate, and perinatal concentrations are similar in normal and growth-restricted pregnancies.
Briana DD; Boutsikou M; Baka S; Gourgiotis D; Marmarinos A; Liosi S; Hassiakos D; Malamitsi-Puchner A
Metabolism; 2011 Apr; 60(4):486-90. PubMed ID: 20488498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
